nach oben

Erschienen in:

01.09.2020 | Clinical study

Risk of cognitive decline with use of anticholinergics among elderly

Erschienen in: Reactions Weekly | Ausgabe 1/2020

Einloggen, um Zugang zu erhalten

Excerpt

Use of anticholinergic medications is associated with an increased risk of progression to mild cognitive impairment (MCI) and accelerated cognitive decline in older adults, particularly in those with risk factors for Alzheimer's disease (AD). …

Weigand AJ, et al. Association of anticholinergic medication and AD biomarkers with incidence of MCI among cognitively normal older adults. Neurology : 2 Sep 2020. Available from: URL: https://doi.org/10.1212/WNL.0000000000010643

Titel: Risk of cognitive decline with use of anticholinergics among elderly
Publikationsdatum: 01.09.2020
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2020
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-020-83364-0

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Risk of cognitive decline with use of anticholinergics among elderly

Excerpt

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2020

Bosutinib

Iodine radioactive

Adalimumab/methotrexate/prednisolone

Nitroglycerin/sodium-chloride

Multiple drugs

Amoxicillin/clavulanic acid